• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术中液体活检作为检测胰腺癌患者胰十二指肠切除术中R1切除的工具:CETUPANC试验(第二部分)

Intraoperative liquid biopsy as a tool for detecting R1 resection during pancreatoduodenectomy in patients with pancreatic carcinoma: the CETUPANC trial (part II).

作者信息

Padillo-Ruiz Javier, Garcia Carlos, Suarez Gonzalo, Blanco Gerardo, Muñoz-Bellvis Luis, Justo Iago, García-Domingo Maria I, Ausania Fabio, Muñoz-Forner Elena, Serrablo Alejandro, Martin Elena, Díez Luis, Cepeda Carmen, Marin Luis, Alamo Jose, Bernal Carmen, Pereira Sheila, Calero Francisco, Laga Imán, Paterna Sandra, Cugat Esteban, Fondevila Constantino, López-Guerra Diego, Gallego-Jiménez Inmaculada, Borrero-Martín Juan José, Gomez-Bravo Miguel Ángel, Tinoco Jose, Sabater Luis

机构信息

Virgen del Rocío University Hospital, IBIS, Seville.

Badajoz University Hospital, University of Extremadura, Badajoz.

出版信息

Int J Surg. 2024 Dec 1;110(12):7798-7805. doi: 10.1097/JS9.0000000000002153.

DOI:10.1097/JS9.0000000000002153
PMID:39806742
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11634100/
Abstract

INTRODUCTION

A positive surgical margin (R1 resection) is a relevant risk factor for local recurrence in patients with pancreatic ductal adenocarcinoma of the pancreas (PDAC). An intraoperative liquid biopsy (ILB) based on tumor cell mobilization could help to detect R1 resection intraoperatively.

OBJECTIVE

To evaluate the potential role of the intraoperative circulating tumor cells (CTCs) and cluster mobilization on the R0/R1 detection.

METHODS

Sixty-three patients with resectable PDAC of the head of the pancreas were prospective enrolled under the CETUPANC trial. Open pancreaticoduodenectomy (PD) was done in all patients. Intraoperative CTCs and clusters were determined during PD.

RESULTS

The overall rate of R1 resection was 34.9% (22/63 patients). Multivariate analysis showed that factors associated with R1 resection (AUC=0.920) were the presence of undifferentiated G3 tumor (P=0.017), microscopic vascular invasion (P=0.016), and the intraoperative increase of both free CTCs and clusters in portal vein determination from the beginning to the end of the surgery (P=0.002 and P=0.005, respectively). A specific logistic regression model, including delta end to baseline CTCs and cluster mobilization to achieve a combined cut-off to detect R1 detection was calculated (AUC=0.799). The obtained R1-index based on ILB had 84% of sensitivity and 68% of specificity to detect R1 resection.

CONCLUSIONS

The ILB based on the intraoperative mobilization of CTCs and clusters from the beginning to the end of the PD was a predictive factor to detect R1 resection in patients with PDAC.

摘要

引言

切缘阳性(R1切除)是胰腺导管腺癌(PDAC)患者局部复发的一个相关危险因素。基于肿瘤细胞动员的术中液体活检(ILB)有助于在术中检测R1切除。

目的

评估术中循环肿瘤细胞(CTC)和细胞簇动员在R0/R1检测中的潜在作用。

方法

63例可切除的胰头PDAC患者前瞻性纳入CETUPANC试验。所有患者均行开放性胰十二指肠切除术(PD)。术中在PD期间测定CTC和细胞簇。

结果

R1切除的总体发生率为34.9%(22/63例患者)。多因素分析显示,与R1切除相关的因素(AUC=0.920)为未分化G3肿瘤的存在(P=0.017)、微血管侵犯(P=0.016),以及手术开始至结束时门静脉测定中游离CTC和细胞簇的术中增加(分别为P=0.002和P=0.005)。计算了一个特定的逻辑回归模型,包括基线至终点CTC的变化量和细胞簇动员,以实现联合截断值来检测R1切除(AUC=0.799)。基于ILB获得的R1指数检测R1切除的敏感性为84%,特异性为68%。

结论

基于PD全程中CTC和细胞簇术中动员的ILB是检测PDAC患者R1切除的一个预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2127/11634100/b946fa4936b0/js9-110-7798-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2127/11634100/563acb5e3f72/js9-110-7798-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2127/11634100/f49b16359b18/js9-110-7798-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2127/11634100/b946fa4936b0/js9-110-7798-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2127/11634100/563acb5e3f72/js9-110-7798-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2127/11634100/f49b16359b18/js9-110-7798-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2127/11634100/b946fa4936b0/js9-110-7798-g003.jpg

相似文献

1
Intraoperative liquid biopsy as a tool for detecting R1 resection during pancreatoduodenectomy in patients with pancreatic carcinoma: the CETUPANC trial (part II).术中液体活检作为检测胰腺癌患者胰十二指肠切除术中R1切除的工具:CETUPANC试验(第二部分)
Int J Surg. 2024 Dec 1;110(12):7798-7805. doi: 10.1097/JS9.0000000000002153.
2
Implications of portal vein/superior mesenteric vein involvement in pancreatic cancer: A comprehensive correlation from preoperative radiological assessment to resection, pathology, and long-term outcomes. A retrospective cohort study.门静脉/肠系膜上静脉受累在胰腺癌中的意义:从术前影像学评估到切除、病理及长期预后的全面相关性。一项回顾性队列研究。
Int J Surg. 2025 Apr 1;111(4):2962-2972. doi: 10.1097/JS9.0000000000002307.
3
Early detection of pancreatic cancer by liquid biopsy "PANLIPSY": a french nation-wide study project.液体活检 "PANLIPSY" 早期检测胰腺癌:一项法国全国性研究项目。
BMC Cancer. 2024 Jun 10;24(1):709. doi: 10.1186/s12885-024-12463-8.
4
A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinoma.对肠系膜上动脉外膜周围剥离在影响胰腺癌胰十二指肠切除术后切缘状态中的作用的系统评价。
HPB (Oxford). 2016 Apr;18(4):305-11. doi: 10.1016/j.hpb.2015.11.009. Epub 2016 Feb 1.
5
Improved survival after pancreatic re-resection of positive neck margin in pancreatic cancer patients. A systematic review and network meta-analysis.胰腺癌患者颈部阳性切缘再次切除后生存率提高:系统评价和网络荟萃分析。
Eur J Surg Oncol. 2021 Jun;47(6):1258-1266. doi: 10.1016/j.ejso.2021.01.001. Epub 2021 Jan 13.
6
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA?一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
7
Frozen section analysis of the pancreatic margin during pancreaticoduodenectomy for cancer: Does extending the resection to obtain a secondary R0 provide a survival benefit? Results of a systematic review.胰腺癌胰十二指肠切除术中胰腺切缘的冰冻切片分析:扩大切除范围以实现二次R0切除是否能带来生存获益?一项系统评价的结果
Pancreatology. 2016 Nov-Dec;16(6):1037-1043. doi: 10.1016/j.pan.2016.09.004. Epub 2016 Sep 13.
8
Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Nonrandomized Controlled Trial.可切除胰腺癌的围手术期改良 FOLFIRINOX:一项非随机对照试验。
JAMA Oncol. 2024 Aug 1;10(8):1027-1035. doi: 10.1001/jamaoncol.2024.1575.
9
Clinical outcomes of preservation versus resection of portal/superior mesenteric vein during pancreaticoduodenectomy in pancreatic cancer patients who respond to neoadjuvant treatment: a retrospective cohort study.新辅助治疗有反应的胰腺癌患者在胰十二指肠切除术中门静脉/肠系膜上静脉保留与切除的临床结局:一项回顾性队列研究
Int J Surg. 2024 Nov 1;110(11):7150-7158. doi: 10.1097/JS9.0000000000002034.
10
Intraoperative revision of a positive proximal resection margin is associated with improved survival in patients undergoing resection for gastroesophageal junction and proximal third gastric adenocarcinoma.对于接受胃食管交界部及近端三分之一胃癌切除术的患者,术中对近端切缘阳性进行修正与生存率提高相关。
J Gastrointest Surg. 2025 Sep;29(9):102123. doi: 10.1016/j.gassur.2025.102123. Epub 2025 Jun 20.

本文引用的文献

1
Effects of the superior mesenteric artery approach versus the no-touch approach during pancreatoduodenectomy on the mobilization of circulating tumour cells and clusters in pancreatic cancer (CETUPANC): randomized clinical trial.肠系膜上动脉入路与无接触入路在胰十二指肠切除术中对胰腺癌循环肿瘤细胞和簇转移的影响(CETUPANC):随机临床试验。
BJS Open. 2024 Oct 29;8(6). doi: 10.1093/bjsopen/zrae123.
2
Early and late recurrence patterns of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: a multicenter study.胰十二指肠切除术后胰腺导管腺癌的早期和晚期复发模式:一项多中心研究。
Int J Surg. 2023 Apr 1;109(4):785-793. doi: 10.1097/JS9.0000000000000296.
3
Quantification and Characterization of CTCs and Clusters in Pancreatic Cancer by Means of the Hough Transform Algorithm.
基于霍夫变换算法对胰腺癌循环肿瘤细胞及其簇的定量与特征分析。
Int J Mol Sci. 2023 Feb 21;24(5):4278. doi: 10.3390/ijms24054278.
4
Advances in Liquid Biopsy Technology and Implications for Pancreatic Cancer.液体活检技术的进展及其对胰腺癌的影响。
Int J Mol Sci. 2023 Feb 20;24(4):4238. doi: 10.3390/ijms24044238.
5
Standard pancreatoduodenectomy versus extended pancreatoduodenectomy with modified retroperitoneal nerve resection in patients with pancreatic head cancer: a multicenter randomized controlled trial.标准胰十二指肠切除术与改良腹膜后神经切除术联合胰头癌胰十二指肠切除术的比较:一项多中心随机对照试验。
Cancer Commun (Lond). 2023 Feb;43(2):257-275. doi: 10.1002/cac2.12399. Epub 2022 Dec 29.
6
Intraoperative Positive Pancreatic Parenchymal Resection Margin: Is It a True Indication of Completion Total Pancreatectomy after Partial Pancreatectomy for Pancreatic Ductal Adenocarcinoma?术中胰腺实质阳性切缘:在胰管腺癌行胰部分切除术后行全胰切除时是否为真正的切缘阳性指征?
Curr Oncol. 2022 Jul 27;29(8):5295-5305. doi: 10.3390/curroncol29080420.
7
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.循环肿瘤 DNA 分析指导 II 期结肠癌辅助治疗。
N Engl J Med. 2022 Jun 16;386(24):2261-2272. doi: 10.1056/NEJMoa2200075. Epub 2022 Jun 4.
8
Intraoperative Radiotherapy for Resectable Pancreatic Cancer Using a Low-Energy X-Ray Source: Postoperative Complications and Early Outcomes.使用低能 X 射线源行可切除胰腺癌术中放疗:术后并发症和早期结果。
Yonsei Med J. 2022 May;63(5):405-412. doi: 10.3349/ymj.2022.63.5.405.
9
Circulating Tumor Cells Enumeration from the Portal Vein for Risk Stratification in Early Pancreatic Cancer Patients.通过门静脉循环肿瘤细胞计数对早期胰腺癌患者进行风险分层
Cancers (Basel). 2021 Dec 7;13(24):6153. doi: 10.3390/cancers13246153.
10
STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery.STROCSS 2021:加强外科学队列研究、横断面研究和病例对照研究报告规范。
Int J Surg. 2021 Dec;96:106165. doi: 10.1016/j.ijsu.2021.106165. Epub 2021 Nov 11.